MYCN oncogene amplification is characteristic of human neuroblastomas, being found in 20% of these childhood cancers, and has been observed to be involved in breast tumorigenesis, with up-regulation being detected in inflammatory breast cancer [10]. Here, MYCN is linked to childhood malignant neoplasm.